Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice
- 1 October 2000
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 279 (4) , H1906-H1912
Abstract
Previous studies have demonstrated that responses to endothelium-dependent vasodilators are absent in the aortas from mice deficient in expression of endothelial nitric oxide synthase (eNOS −/− mice), whereas responses in the cerebral microcirculation are preserved. We tested the hypothesis that in the absence of eNOS, other vasodilator pathways compensate to preserve endothelium-dependent relaxation in the coronary circulation. Diameters of isolated, pressurized coronary arteries from eNOS −/−, eNOS heterozygous (+/−), and wild-type mice (eNOS +/+ and C57BL/6J) were measured by video microscopy. ACh (an endothelium-dependent agonist) produced vasodilation in wild-type mice. This response was normal in eNOS +/− mice and was largely preserved in eNOS −/− mice. Responses to nitroprusside were also similar in arteries from eNOS +/+, eNOS +/−, and eNOS −/− mice. Dilation to ACh was inhibited by N G-nitro-l-arginine, an inhibitor of NOS in control and eNOS −/− mice. In contrast, trifluoromethylphenylimidazole, an inhibitor of neuronal NOS (nNOS), decreased ACh-induced dilation in arteries from eNOS-deficient mice but had no effect on responses in wild-type mice. Indomethacin, an inhibitor of cyclooxygenase, decreased vasodilation to ACh in eNOS-deficient, but not wild-type, mice. Thus, in the absence of eNOS, dilation of coronary arteries to ACh is preserved by other vasodilator mechanisms.Keywords
This publication has 40 references indexed in Scilit:
- How to assess endothelial function in human blood vesselsJournal Of Hypertension, 1999
- Acetylcholine‐induced relaxation in blood vessels from endothelial nitric oxide synthase knockout miceBritish Journal of Pharmacology, 1999
- Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoformFundamental & Clinical Pharmacology, 1997
- Alteration of flow‐induced dilatation in mesenteric resistance arteries of L‐NAME treated rats and its partial association with induction of cyclo‐oxygenase‐2British Journal of Pharmacology, 1997
- Effects of a Novel Inhibitor of Guanylyl Cyclase on Dilator Responses of Mouse Cerebral ArteriolesStroke, 1997
- Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium‐dependent relaxation to bradykinin in human small resistance‐like coronary arteriesBritish Journal of Pharmacology, 1997
- Selective Guanylyl Cyclase Inhibitor Reverses Nitric Oxide-Induced VasorelaxationHypertension, 1997
- Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.Journal of Clinical Investigation, 1995
- Prostaglandin endoperoxide synthase: structure and catalysisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Biosynthesis and Metabolism of Endothelium-Derived Nitric OxideAnnual Review of Pharmacology and Toxicology, 1990